Phibro Animal Health Co. (NASDAQ: PAHC – Rated ) was the recipient of a sharp increase in short interest in December. As of December 15, short interests totaled 459,900 shares, an increase of 19.4% from 385,300 shares on November 30. Based on an average volume of 183,600 shares, the short interest rate is currently 2.5 days. Currently, 2.3% of the company’s shares are short-sold.
Analyst Rating Changes
Several research analysts recently weighed in on the company. StockNews.com downgraded Phibro Animal Health from a “buy” rating to a “hold” rating in a research report on Friday, November 11th. Morgan Stanley cut their price target on Phibro Animal Health from $21.00 to $20.00 and set an “equal weight” rating on the stock in a research note on Thursday, November 10th. Barclays cut their price target on Phibro Animal Health from $22.00 to $17.00 and set an “underweight” rating on the company in a research report on Friday, September 16th. Finally, Roth Capital started coverage on Phibro Animal Health in a research report on Wednesday, December 21st. They issued a “buy” rating and an $18.00 price target for the company. One equity research analyst has rated the stock with a sell rating, two have given a hold rating and one has assigned a buy rating to the stock. According to MarketBeat.com, Phibro Animal Health has an average rating of “hold” and an average price target of $18.33.
Hedge funds take part in Phibro Animal Health
Hedge funds have recently overweight or underweight the stock. KBC Group NV acquired a new position at Phibro Animal Health in the second quarter for approximately $30,000. UBS increased its stake in Phibro Animal Health by 3,713.7% in the third quarter. UBS Group AG now owns 4,462 shares of the company worth $59,000 after buying an additional 4,345 shares last quarter. Gladius Capital Management LP acquired a new position at Phibro Animal Health in the second quarter for approximately $68,000. Tower Research Capital LLC TRC increased its stake in Phibro Animal Health by 430.4% in the third quarter. Tower Research Capital LLC TRC now owns 5,378 shares of the company worth $71,000 after buying an additional 4,364 shares last quarter. Finally, the Kentucky Teachers’ Retirement System purchased a new position in Phibro Animal Health stock worth approximately $71,000 during the third quarter. Institutional investors and hedge funds own 49.21% of the company.
Phibro Animal Health stocks down 0.4%
Phibro Animal Health shares were down 5 cents at $13.41 in midday trading Friday. The stock’s volume was 111,903 shares, compared with its average volume of 181,734 shares. Phibro Animal Health had a 12-month low of $11.75 and a 12-month high of $22.16. The company has a market capitalization of $543.11 million, a P/E ratio of 11.66, a PEG ratio of 7.36, and a beta of 0.58. The company’s 50-day moving average is $13.33 and its 200-day moving average is $15.61. The company has a current ratio of 3.30, a quick ratio of 1.68, and a debt-to-equity ratio of 1.72.
Phibro Animal Health Declares Dividend
The company also recently declared a quarterly dividend, which is paid on Wednesday, December 21. Shareholders of record on Wednesday, November 30 received a dividend of $0.12 per share. The ex-dividend date for this dividend is Tuesday, November 29. This represents an annualized dividend of $0.48 and a yield of 3.58%. Phibro Animal Health’s dividend payout ratio (DPR) currently stands at 41.74%.
About Phibro Animal Health
Phibro Animal Health Corporation develops, manufactures and supplies a line of animal health and mineral nutrition products for food and companion animals. It operates through three segments: Animal Health, Mineral Nutrition and Performance Products. The company develops, manufactures and sells products for poultry, swine, beef and dairy cattle, aquaculture and dogs.
This breaking news alert is powered by MarketBeat’s narrative science technology and financial data to provide readers with the fastest and most accurate coverage. This story was reviewed by MarketBeat’s editorial team before publication. Please send any questions or comments about this story to firstname.lastname@example.org.
Before you consider Phibro Animal Health, you’ll want to hear this.
MarketBeat tracks Wall Street’s highest-rated and top-performing research analysts and the stocks they recommend to clients on a daily basis. MarketBeat has identified five stocks top analysts are quietly telling their clients to buy now before the broader market rallies…and Phibro Animal Health isn’t on the list.
While Phibro Animal Health currently has a Hold rating among analysts, the top-rated analysts see these five stocks as better buys.
Check out five stocks here